Optimal control theory as a method for designing multidrug adaptive therapy regimens
Afton Widdershins, Elsa Hansen, Andrew Read, Raymond Hohl,
Dec 2026,
In: NPJ systems biology and applications
Date: Dec 2026
Exploring the Isoprenoid Biosynthesis Pathway’s Role in Oncogenic Viruses
Louise N. Blaha, Jeffrey D. Neighbors, Richa Sandeep, Akhila Kondaka, Raymond J. Hohl,
Jun 2026,
In: Viruses
Date: Jun 2026
Does Ras/Rho Have Skin in the Game
Louise N. Blaha, Nicole M. Derosia, Jeffrey D. Neighbors, Raymond J. Hohl,
May 2026,
In: Cancers
Date: May 2026
Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02
Akshita Khosla, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Myles Nickolich, Hong Zheng, Seema Naik, Christopher Ehmann, David Claxton, Witold Rybka, Jeffrey Sivik, Joseph Mierski, Brooke Silar, Caitlin Vajdic, Raymond Hohl, Hiroko Shike, Shin Mineishi, Kentaro Minagawa,
Nov 2024,
In: Blood Transfusion
Date: Nov 2024
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation
Emma Zulch, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Myles Nickolich, Hong Zheng, Seema Naik, Witold Rybka, Christopher Ehmann, Jeffrey Sivik, Jseph Mierski, Brooke Silar, Caitlin Vajdic, Robert Greiner, Valerie Brown, Raymond Hohl, David Claxton, Hiroko Shike, Catharine...,
Aug 2024,
In: Leukemia Research
Date: Aug 2024
The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma
Emma G. Guare, Cory M. Hale, Jeffrey Sivik, Erik Lehman, Yoshika Inoue, Kevin Rakszawski, Natthapol Songdej, Myles Nickolich, Hong Zheng, Seema Naik, David Claxton, Witold Rybka, Raymond Hohl, Shin Mineishi, Kentaro Minagawa, Catharine I. Paules,
2024,
In: Transplant Infectious Disease
Date: 2024
Thalassemia
Sarah A. Holstein, Ray J. Hohl,
Jan 1 2024,
In: Conn's Current Therapy 2025
Date: Jan 1 2024
Thalassemia
Sarah A. Holstein, Raymond J. Hohl,
Jan 1 2023,
In: Conn's Current Therapy 2024
Date: Jan 1 2023
RNAseq reveals extensive metabolic disruptions in the sensitive SF-295 cell line treated with schweinfurthins
J. S. Weissenrieder, J. D. Weissenkampen, J. L. Reed, M. V. Green, C. Zheng, J. D. Neighbors, D. J. Liu, Raymond J. Hohl,
Dec 2022,
In: Scientific reports
Date: Dec 2022
Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide
Neal Shah, Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik, Baldeep Wirk, Witold Rybka, Christopher Ehmann, Brook Silar, Caitlin Vajdic, Joseph Mierski, Shouhao Zhou, Hiroko Shike, Robert Greiner, Valerie Brown, Raymond Hohl, David Claxton, Shin Mineishi, Kentaro Minagawa, ...,
Dec 2022,
In: Leukemia Research
Date: Dec 2022
A phase II study of temozolemide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W. K.A. Yung, R. E. Albright, J. Olson, R. Fredericks, K. Fink, M. D. Prados, M. Brada, A. Spence, R. J. Hohl, W. Shapiro, M. Glantz, H. Greenberg, R. G. Selker, N. A. Vick, R. Rampling, H. Friedman, P. Phillips, J. Bruner, N. Yue, D. Osoba, S. Zaknoen, V. A. Levin,
2000,
In: British Journal of Cancer
Citations: 904
Clinical and biologic activity of the famesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias
Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann, David W. End, John J. Wright, Kees Bol, Ivan Horak, Michael L. Tidwell, Jane Liesveld, Timothy J. Kottke, Dawn Ange, Laxmi Buddharaju, Ivana Gojo, W. Edward Highsmith, Robert T. Belly, Raymond J. Hohl, Mary Ellen Rybak, Alain Thibault, Joseph Ros...,
Jun 1 2001,
In: Blood
Citations: 448
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer
Alain Thibault, Dvorit Samid, Anne C. Tompkins, William D. Figg, Michael R. Cooper, Raymond J. Hohl, Jane Trepel, Bertrand Liang, Nicholas Patronas, David J. Venzon, Eddie Reed, Charles E. Myers,
Mar 1996,
In: Clinical Cancer Research
Citations: 358
O<sub>2</sub><sup>⋅−</sup> and H<sub>2</sub>O<sub>2</sub>-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
Joshua D. Schoenfeld, Zita A. Sibenaller, Kranti A. Mapuskar, Brett A. Wagner, Kimberly L. Cramer-Morales, Muhammad Furqan, Sonia Sandhu, Thomas L. Carlisle, Mark C. Smith, Taher Abu Hejleh, Daniel J. Berg, Jun Zhang, John Keech, Kalpaj R. Parekh, Sudershan Bhatia, Varun Monga, Kellie L. Bodeker, Lo...,
Apr 10 2017,
In: Cancer Cell
Citations: 348
Isoprenoids
Sarah A. Holstein, Raymond J. Hohl,
Apr 2004,
In: Lipids
Citations: 207
Phase i and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction
Antonius A. Miller, Daryl J. Murry, Kouros Owzar, Donna R. Hollis, Erin B. Kennedy, Ghassan Abou-Alfa, Apurva Desai, Jimmy Hwang, Miguel A. Villalona-Calero, E. Claire Dees, Lionel D. Lewis, Marwan G. Fakih, Martin J. Edelman, Fred Millard, Richard C. Frank, Raymond J. Hohl, Mark J. Ratain,
Apr 10 2009,
In: Journal of Clinical Oncology
Citations: 193
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction
Alan P. Venook, Merrill J. Egorin, Gary L. Rosner, Donna Hollis, Sridhar Mani, Michael Hawkins, John Byrd, Raymond Hohl, Daniel Budman, Neal J. Meropol, Mark J. Ratain,
Jul 2000,
In: Journal of Clinical Oncology
Citations: 193
VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML
Liru Wang, Bei Jia, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Seema Naik, Muhammad R. Khawaja, Jeff Sivik, Junyan Han, Raymond J. Hohl, Hong Zheng,
Jul 9 2018,
In: OncoImmunology
Citations: 159
Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation
C. K. Lee, R. D. Gingrich, Raymond Hohl, K. A. Ajram,
1995,
In: Bone Marrow Transplantation
Citations: 150
Cyclodextrin complexation
Jichao Kang, Vijay Kumar, Dong Yang, Priyanka Roy Chowdhury, Raymond J. Hohl,
2002,
In: European Journal of Pharmaceutical Sciences
Citations: 144
